A great deal of work has been done over the past decade to raise awareness of The Sinclair Method (TSM) across the UK. The journey has had it’s share of challenges, yet every obstacle has strengthened our purpose.

This is the story of how we faced and overcame every challenge, leading to a new era of expanding public awareness and acceptance of this transformative treatment in the UK

This is the story of how we overcame these issues and are now at the point of ever-increasing public awareness of this life-saving treatment in the UK.

Gary Bell, featured in the One Little Pill documentary, was the first person to create a website dedicated to TSM. Soon after doing so, he opted to hand the reins of this website over to our Founders, Joanna and Adrian.

At this point, our Founders chose to rebrand the business as C3 Europe. This was necessary as, unbeknown to Gary, it was illegal to have the name of a prescription-only medication in the website name and URL. Discussions with Claudia Christian (also from “One Little Pill”) followed and, upon learning that a UK charity could be set up with the aim of both raising awareness and helping others (mirroring C Three Foundation in the US in many ways), we set about founding the C3 Foundation Europe charity. Though small in scale, this meant our work could truly begin in earnest and positive momentum began to build!

In 2019, C3 Foundation Europe achieved national recognition, when we were declared the winner of that year’s “Health & Social Care Award” by the UK’s leading ‘for-charity’ organisation, Charity Today.

We began to speak with other healthcare organisations with a view to making The Sinclair Method a more accepted treatment. We asked questions to the government of the time in Parliament. Sadly, this was when we discovered just how unrewarding an experience it could be, trying to lobby the government as a lone voice; quite soul-destroying to have so much work quickly disregarded by the then Health Secretary.

We realised that if the manufacturer of Nalmefene (Lundbeck Pharmaceuticals) had been unable to gain more traction with the release of Nalmefene on the NHS, then solo efforts were clearly doomed to fail!

Meanwhile, work with one particular healthcare provider continued in the background and Sinclair Method UK Limited was incorporated to enable us to work alongside this particular organisation.

In early 2020, when the impact of the pandemic began to be felt across the UK, like a lot of other smaller charities, we lost the small amount of funding we were receiving. A decision on the future of the charity had to be made, and it was ultimately decided to close the charity and focus on the private business of Sinclair Method UK Ltd.

The pandemic created a massive increase in the demand for mental health service providers in the UK. The organisation we were working with found themselves inundated with NHS mental health patients and the building of their addiction service – which would, ultimately, include The Sinclair Method was temporarily postponed until after the pandemic-related demand on their services eased.

Sinclair Method UK Limited professional relationship with Dr Janey Merron began in 2018 , when Dr. Merron and Sinclair Method UK Ltd began working hand in hand to take Sinclair Method UK Ltd. services UK-wide and beyond the UK, providing The Sinclair Method on a private basis.

The need for a strategic partnership with a pharmacy came next. We then contacted a pharmacy to dispense Dr Merron’s Naltrexone and Nalmefene prescriptions worldwide, enabling us to provide The Sinclair Method as far afield as Dubai, Australia, New Zealand and China, in addition to much of Europe. We were even able to reach countries where naltrexone was not approved as a medication!

We have continued to provide this service, improving and adapting as we go. We have seen TSM and business go from strength to strength. As we continued to grow the business in the face of ever-increasing demand, Dr Rachael Jolley and Dr Wisam Tatari joined us and began issuing prescriptions; we now partnering with pharmacies across the UK.

Most recently, we were honoured to welcome Yale University-trained Professor Susannah Hart onboard. Professor Hart is currently working on writing TSM-related position papers for submission to some of the world’s leading medical publications.

These enquiries came primarily from the demographic of over-50’s drinking a bottle of wine a night – almost the precise demographic that Nalmefene was expected to reach when approved in late 2013. We will always be grateful for the bravery of the reporter, Esther Walker, who opened up about her own drinking and her desire to simply regain control and drink less. We were later informed by Esther that the article had been a once-in-a-lifetime article for her, and that it featured in the top 10 read articles featured in The Times for 2024, reportedly being viewed several million times.

A few months later, a second article featuring another reporter using our TSM service was published in another national newspaper, The Daily Telegraph.

Although we are currently only able to offer The Sinclair Method privately, we have not forgotten our roots as a charitable organisation and we take social responsibility and charitable giving very seriously. Sinclair Method UK Ltd has been the main sponsor of the UK’s national Charity Week every December since 2021 and, since 2023, we have been the main partner of the national Charity Today Awards. We reward volunteers with hampers every December as part of the UK Charity Week campaign, and donate to a number of other small charities, too.

Moving forward, there is still much to be done and our dream of spreading the message and raising awareness of our life-saving treatment, making it available to all who need it remains a core objective of Sinclair Method UK Limited.

For further information on The Sinclair Method in the UK, please go to Sinclair Method UK Ltd www.SinclairMethodUK.com